Get The Daily Rip

Stocktwits Top 25 – Week 33 πŸ“‰

Welcome to the Stocktwits Top 25 Newsletter for Week 33 of 2023!

The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD) and tracks their performances over time.Β 

Here are the Stocktwits Top 25 Lists for Week 33:

P.S. To help you understand this data further, check out our FAQ page, and feel free to reach out if you have questions!


Standard and Poor's 500

ST Top 25 S&P 500

The S&P 500 Top 25 list (-2.04%) performed in line with the S&P 500 index (-2.11%).

There were three major changes to the list this week.

Joining: Eli Lilly (+3.44%), Arista Networks (+3.20%), and Applied Materials (+2.76%).

Leaving: Davita Inc (-6.27%), Old Dominion Freight Line (-4.21%), and Fleetcor Technologies (-1.25%).

Check out how the momentum meter has performed vs. the S&P 500 index this year:


NASDAQ 100

The Large-Cap Nasdaq 100

The Nasdaq 100 Top 25 list (-2.61%) underperformed the Nasdaq 100 index (-2.22%).

There were two major changes to the list this week.

Joining: Crowdstrike Holdings (-0.96%) and Cadence Design Systems (-2.44%).

Leaving: Warner Bros Discovery (-6.72%) and Netflix (-4.06%).


RUSSELL 2000

The Growth-Centric Russell 2000

The Russell 2000 Top 25 list (-6.86%) underperformed the Russell 2000 index (-3.41%).

There were three major changes to the list this week.

Joining: Immunogen (+8.84%), Oscar Health (-4.53%), and Daktronics Inc (+1.13%).

Leaving: Arlo Technologies (-8.73%), Holley Inc (-25.44%), and Cleanspark Inc (-20.25%).


🐢🐢🐢

ST Top 25 TOP DAWG OF THE WEEK 🐢

The Top 25 lists’ Top Dawg was Immunogen Inc., which rallied 8.84%. πŸ“ˆ

The mid-cap, commercial-stage biotechnology company focuses on developing and commercializing antibody-drug conjugates (ADCs) for cancer patients. There didn’t appear to be any news related to the stock this week, though the entire biotech space remains in focus with investors. 🀷

$IMGN is up 215.32% YTD.

See Y’all Next Week πŸ€™